Lee Pharmaceuticals | Income Statement
Fiscal year is October-September. All values USD Thousands.
2000
2001
2002
2003
2004
Sales/Revenue
8,801.00
8,469.00
9,226.00
8,758.00
8,533.00
Cost of Goods Sold (COGS) incl. D&A
4,205.00
4,386.00
4,999.00
5,252.00
5,499.00
Gross Income
4,596.00
4,083.00
4,227.00
3,506.00
3,034.00
SG&A Expense
3,785.00
3,454.00
3,867.00
4,170.00
3,869.00
Unusual Expense
-
-
659.00
254.00
39.00
Non Operating Income/Expense
64.00
84.00
165.00
665.00
512.00
Interest Expense
859.00
790.00
777.00
851.00
867.00
Pretax Income
16.00
77.00
911.00
1,104.00
1,229.00
Consolidated Net Income
16.00
77.00
911.00
1,104.00
1,229.00
Net Income
16.00
77.00
911.00
1,104.00
1,229.00
Net Income After Extraordinaries
16.00
201.00
911.00
1,104.00
1,229.00
Net Income Available to Common
16.00
77.00
911.00
1,104.00
1,229.00
EPS (Basic)
0.00
0.01
0.22
0.27
0.30
Basic Shares Outstanding
4,135.20
4,135.20
4,135.20
4,135.20
4,135.20
EPS (Diluted)
0.00
0.01
0.22
0.27
0.30
Diluted Shares Outstanding
4,135.20
4,135.20
4,135.20
4,135.20
4,135.20
EBITDA
1,848.00
1,286.00
761.00
293.00
422.00
About Lee Pharmaceuticals
View Profile
